Filing Details
UTAH MEDICAL PRODUCTS INC (NASDAQ:UTMD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:UTMD
UTAH MEDICAL PRODUCTS INC (UTMD) Files Quarterly Report for Q0
UTAH MEDICAL PRODUCTS INC (NASDAQ:UTMD) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
At publication ·
What changed
UTAH MEDICAL PRODUCTS INC (NASDAQ:UTMD) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Utah Medical Products Inc (NASDAQ: UTMD) filed its quarterly 10-Q report on August 12, 2026, providing unaudited financial statements and management commentary on recent business performance.
- The company's stock trades at $72.13 with a market capitalization of $184.8 million as of the filing date.
- The 10-Q filing typically contains timely information about emerging trends, updated risk factors, and changes in business conditions since the previous filing, though it is less detailed than the annual 10-K report.
Market Context
UTAH MEDICAL PRODUCTS INC's stock currently trades at $72.13 with a market capitalization of $184.8M.
The 10-Q provides UTAH MEDICAL PRODUCTS INC's quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for UTAH MEDICAL PRODUCTS INC are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View UTMD Stock Page
Frequently Asked Questions
Where can I read UTMD's SEC filings?
Browse all filings on our UTMD SEC filings page.
What types of SEC filings does UTAH MEDICAL PRODUCTS INC file?
Public companies like UTAH MEDICAL PRODUCTS INC file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.